Investment in small-molecule protein degraders is surging, but their drawbacks, limitations and risks are becoming clear. Click to show full abstract
Investment in small-molecule protein degraders is surging, but their drawbacks, limitations and risks are becoming clear.
               
Click one of the above tabs to view related content.